Glycolysis: Overview and Strategy

Every second, a resting human burns roughly 2 mg of glucose per kilogram of body mass. This happens through a ten-reaction sequence. That sequence predates mitochondria, chloroplasts, and quite possibly the last universal common ancestor. Glycolysis is the metabolic bedrock. It runs in anaerobic mud bacteria, in your red blood cells (which have no mitochondria at all). It also runs in the sprinting muscle fiber that has outrun its oxygen supply. Understanding why the pathway is built the way it is matters. Why does it spend ATP before it makes any? Why does it split a six-carbon sugar exactly in half? Why is one step a redox reaction, and only one? Answering these questions turns a memorized list of ten enzyme names into a coherent piece of chemical engineering. The central puzzle glycolysis solves is this: glucose is a stable, low-energy molecule. Oxidizing it fully to CO₂ releases about 2870 kJ/mol. But that combustion energy is locked behind large activation barriers. It cannot be tapped in one step. Cells need that energy released in small, phosphoryl-transfer-sized packets. These packets can be coupled to ATP synthesis via ATP as the Cellular Energy Currency. Glycolysis is the first, most universal solution. It is a nine-enzyme (ten-step, counting a reaction catalyzed twice) relay. It converts one glucose into two pyruvate. The net profit is 2 ATP and 2 NADH, entirely without oxygen. The strategic architecture has two acts. An investment phase (steps 1–5) spends 2 ATP to phosphorylate and destabilize glucose. It then cleaves glucose into two three-carbon phosphorylated sugars. A payoff phase (steps 6–10) oxidizes each three-carbon unit. This harvests that oxidation energy as ATP and NADH. The ATP harvest follows Reduction Potentials and Electron Flow logic applied to substrate-level phosphorylation. It finishes with two more ATP-generating steps per triose. That is four ATP total, for a net of +2. This article works through the pathway's logic reaction by reaction. It derives the net stoichiometry and the free-energy accounting. It also sets up the branch points. These are what happens to pyruvate and to the electron carrier NADH. These branch points are treated in full in Fates of Pyruvate and Fermentation. The atom-by-atom mechanisms appear in Glycolysis: Preparatory Phase. By the end you should be able to reconstruct the entire pathway from its design constraints. These constraints are mass balance, redox balance, and phosphoryl-group bookkeeping. You should manage this rather than relying on rote memory. You should also be able to defend, mechanistically, why each investment step exists. And you should be able to explain why the payoff phase is a mirror-image use of the same chemistry. That chemistry — phosphorylation, isomerization, phosphorylation, cleavage — runs over an oxidative core.

Key takeaways

Glycolysis converts one glucose (C₆) into two pyruvate (C₃), net yielding 2 ATP and 2 NADH per glucose, with no O₂ required.
The pathway has two phases: investment (steps 1–5, consumes 2 ATP, splits C₆ into 2×C₃) and payoff (steps 6–10, run twice, makes 4 ATP + 2 NADH).
Only one step (glyceraldehyde-3-phosphate dehydrogenase) is a redox reaction; it couples aldehyde oxidation to acyl-phosphate formation, the high-energy intermediate that pays for ATP synthesis two steps later.
Aldolase cleaves fructose-1,6-bisphosphate into two triose phosphates, one of which (DHAP) must be isomerized before it can proceed — this is why the payoff phase is credited "×2."
Three steps (hexokinase, PFK-1, pyruvate kinase) are essentially irreversible under cellular conditions and are the pathway's control points.
Net reaction: glucose + 2 NAD⁺ + 2 ADP + 2 Pᵢ → 2 pyruvate + 2 NADH + 2 H⁺ + 2 ATP + 2 H₂O.
Key idea: glycolysis is a two-act redox/phosphorylation relay — spend ATP to destabilize and split glucose, then let a single oxidation step generate a high-energy phosphate intermediate that is cashed in twice per triose for a net profit of 2 ATP and 2 NADH.

The core insight

Glycolysis converts the chemical potential energy of glucose into phosphoryl-transfer potential by first investing ATP to raise the substrate to an unstable, cleavable form, then harvesting that instability through one obligatory oxidation (the GAPDH step) whose energy is captured as a mixed anhydride (1,3-bisphosphoglycerate) and spent twice more downstream — yielding a net 2 ATP and 2 NADH per glucose, entirely independent of oxygen.

Where this lives today

Glycolysis is not a museum piece — it is a live pharmacological and industrial target. Cancer metabolism: many tumors exhibit the Warburg effect, converting glucose to lactate at high rates even with adequate oxygen, and hexokinase-2 and PFK-1 isoforms are actively pursued as drug targets (e.g., 2-deoxyglucose as a glycolytic inhibitor in clinical trials, and PET imaging with the glucose analog ¹⁸F-fluorodeoxyglucose exploits hexokinase's broad substrate tolerance to visualize hypermetabolic tumors). Antiparasitic drug design: trypanosomes causing African sleeping sickness rely almost exclusively on glycolysis (compartmentalized in organelles called glycosomes) for ATP, making glycolytic enzymes attractive, parasite-selective targets distinct enough in sequence from human orthologs to allow selective inhibition. Industrial biotechnology: yeast fermentation (glycolysis feeding into ethanol fermentation) remains the basis of brewing, baking, and biofuel ethanol production at multi-billion-liter annual scale; engineered glycolytic flux control is a major lever in metabolic engineering of microbial cell factories for producing organic acids, amino acids, and biofuels. Clinical diagnostics: measuring lactate and pyruvate ratios in blood helps diagnose mitochondrial disease and tissue hypoxia, directly reflecting the anaerobic/aerobic balance struck by the pathway discussed here. Red blood cell storage: blood banks add glucose and adjust pH specifically to sustain erythrocyte glycolytic flux, since red cells depend on this pathway exclusively (plus the associated 2,3-bisphosphoglycerate shunt, which modulates hemoglobin oxygen affinity) for the entire storage-shelf life of donated blood.

Ask the tutor: Why does the cell "choose" to invest 2 ATP before ever cleaving glucose, rather than evolving a single-step cleavage mechanism that avoids the ATP cost entirely?

The physical picture — thorough prose

Glucose is chemically unreactive at physiological temperature: its hydroxyl groups and cyclic hemiacetal form are kinetically stable, and nothing about the naked sugar makes it want to fragment. Glycolysis's first move, therefore, is not oxidation but activation: phosphorylating glucose at C6 (hexokinase) converts a neutral, membrane-permeant sugar into a charged, membrane-trapped, and — crucially — destabilized species. A second phosphorylation (phosphofructokinase-1, PFK-1) adds a phosphate at C1 (after isomerization to fructose) which does two things simultaneously: it commits the sugar irreversibly to glycolysis, and it creates a symmetric, doubly-phosphorylated six-carbon molecule, fructose-1,6-bisphosphate (F1,6BP), that is perfectly set up for a retro-aldol cleavage down the middle. That cleavage (aldolase) is the geometric heart of the pathway: F1,6BP splits into dihydroxyacetone phosphate (DHAP, a ketose) and glyceraldehyde-3-phosphate (GAP, an aldose). Only GAP is a direct substrate for the next enzyme, so triose phosphate isomerase (TPI) interconverts DHAP and GAP, funneling essentially all the carbon into a single stream. This is why textbooks say "two GAP" emerge from one glucose — one directly, one via isomerization — and why every downstream step from GAP onward is counted ×2 per glucose. The payoff phase is where the chemistry actually pays for itself. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) performs the pathway's single redox event: it oxidizes the aldehyde of GAP to a carboxylic acid oxidation level while trapping the energy of that oxidation as a mixed acid-phosphate anhydride (1,3-bisphosphoglycerate, 1,3-BPG) rather than releasing it as heat. The energy of that acyl-phosphate bond (ΔG°′ of hydrolysis ≈ −49.3 kJ/mol) is then transferred directly to ADP by phosphoglycerate kinase — the pathway's first ATP-generating, substrate-level phosphorylation. A second, mechanistically unrelated high-energy phosphate is generated later: enolase dehydrates 2-phosphoglycerate to phosphoenolpyruvate (PEP), whose enol-phosphate has an enormous hydrolysis free energy (ΔG°′ ≈ −61.9 kJ/mol) because the product, pyruvate's enol form, immediately tautomerizes to the far more stable keto form. Pyruvate kinase cashes in that phosphate to make the second ATP.

Figure

Glycolysis at a glance — investment and payoff phases

Figure

Why aldolase's product must be doubled — carbon accounting

The core ideas — governing relationships

The pathway's stoichiometry, energetics, and control logic reduce to a handful of quantitative relationships.

Net reaction (per glucose):

\text{Glucose} + 2\,\text{NAD}^+ + 2\,\text{ADP} + 2\,P_i \;\longrightarrow\; 2\,\text{Pyruvate} + 2\,\text{NADH} + 2\,\text{H}^+ + 2\,\text{ATP} + 2\,\text{H}_2\text{O}

where: glucose (C₆H₁₂O₆) is split via a C₃ symmetric intermediate; NAD⁺ is the sole electron acceptor; Pᵢ is inorganic phosphate incorporated by GAPDH (not by ATP hydrolysis); ATP arises exclusively via substrate-level phosphorylation, twice per triose.

Investment/payoff balance:

\Delta \text{ATP}_{\text{net}} \;=\; \underbrace{(-1) + (-1)}_{\text{steps 1, 3}} \;+\; \underbrace{2\times[(+1)+(+1)]}_{\text{steps 7, 10, per triose}} \;=\; +2

where: the factor of 2 in the payoff term reflects that one glucose yields two GAP molecules, each independently traversing steps 6–10.

Standard free energy of the pathway (glucose → 2 pyruvate, aerobic accounting):

\Delta G^{\circ\prime}_{\text{glycolysis}} \approx -146\ \text{kJ/mol}

where: this is the sum of the ten individual ΔG°′ values; it is substantially less negative than glucose's full combustion energy (−2870 kJ/mol) because most of the chemical energy remains stored in pyruvate and in NADH, to be extracted later by the citric acid cycle and oxidative phosphorylation.

Actual (physiological) free energy is far more negative than ΔG°′:

\Delta G = \Delta G^{\circ\prime} + RT\ln Q

where: $Q$ uses real intracellular concentrations of glucose, ATP, ADP, Pᵢ, pyruvate, NAD⁺, NADH; because [ATP]/[ADP][Pᵢ] and other ratios are held far from equilibrium by continuous flux, the cellular ΔG for the overall pathway is roughly −70 to −100 kJ/mol, making glycolysis effectively irreversible in vivo despite several individually near-equilibrium steps.

Standard reduction potential coupling at GAPDH:

\Delta G^{\circ\prime} = -nF\Delta E^{\circ\prime}

where: $n=2$ electrons are transferred from the GAP aldehyde carbon to NAD⁺; $F = 96{,}485$ C/mol; $\Delta E^{\circ\prime}$ is the difference between the NAD⁺/NADH couple (−0.320 V) and the effective potential of the 1,3-BPG/GAP (acyl-phosphate/aldehyde) couple, arranged so that oxidation is favorable enough to also drive phosphate incorporation into a high-energy linkage — this is the direct link to Reduction Potentials and Electron Flow applied at the level of a single enzyme rather than a respiratory chain.

Derivation ANet ATP yield from first principles — counting investment against payoff

Goal: derive the net ATP yield per glucose using only the mass-balance requirement that F1,6BP cleaves into two three-carbon units and each traverses the payoff phase independently.

Step 1 — Investment phase spends exactly 2 ATP. Hexokinase transfers the γ-phosphate of ATP to glucose C6, forming glucose-6-phosphate (G6P) and ADP:

\text{Glucose} + \text{ATP} \rightarrow \text{G6P} + \text{ADP}, \qquad \Delta G^{\circ\prime} = -16.7\ \text{kJ/mol}

Phosphoglucose isomerase converts G6P to fructose-6-phosphate (F6P) with no ATP involvement (an intramolecular aldose–ketose isomerization). PFK-1 then transfers a second phosphate:

\text{F6P} + \text{ATP} \rightarrow \text{F1,6BP} + \text{ADP}, \qquad \Delta G^{\circ\prime} = -14.2\ \text{kJ/mol}

Total ATP spent so far: exactly 2, regardless of anything downstream — this is fixed by the requirement that F1,6BP carry two phosphate groups (one at C1, one at C6) before cleavage.

Step 2 — Aldolase cleaves symmetrically; one product needs isomerization. F1,6BP is cleaved by a retro-aldol mechanism (a Schiff-base intermediate in class I aldolases, a metal-stabilized enolate in class II) between C3 and C4, giving:

\text{F1,6BP} \rightarrow \text{DHAP (C1–C3)} + \text{GAP (C4–C6)}

DHAP is a ketose (phosphate on C1 of a three-carbon ketone) and cannot enter GAPDH directly. Triose phosphate isomerase converts it to GAP:

\text{DHAP} \rightleftharpoons \text{GAP}, \qquad \Delta G^{\circ\prime} = +7.5\ \text{kJ/mol}

Although this step is endergonic at standard state, the cell keeps [GAP] low by continuously draining it through GAPDH, so the reaction runs forward under real conditions (Le Chatelier's principle applied to a near-equilibrium enzyme). Net result: two molecules of GAP enter the payoff phase per one glucose entering the investment phase. This factor of two is not a bookkeeping convenience — it is forced by the stoichiometry of a six-carbon molecule splitting into two three-carbon halves.

Step 3 — Each GAP generates 2 ATP in the payoff phase. GAPDH oxidizes the aldehyde and incorporates inorganic phosphate to form the mixed anhydride 1,3-bisphosphoglycerate, reducing NAD⁺ to NADH (no ATP yet — this step stores energy in a covalent acyl-phosphate bond rather than releasing it). Phosphoglycerate kinase then transfers that phosphate to ADP:

\text{1,3-BPG} + \text{ADP} \rightarrow \text{3-phosphoglycerate} + \text{ATP}, \qquad \Delta G^{\circ\prime} = -18.8\ \text{kJ/mol}

This is the first ATP-generating step, and it occurs once per GAP — i.e., twice per glucose. After phosphoglycerate mutase repositions the phosphate (3PG → 2PG) and enolase dehydrates it to PEP, pyruvate kinase transfers PEP's phosphate to a second ADP:

\text{PEP} + \text{ADP} \rightarrow \text{Pyruvate} + \text{ATP}, \qquad \Delta G^{\circ\prime} = -31.4\ \text{kJ/mol}

This is the second ATP-generating step, again once per GAP, i.e. twice per glucose.

Step 4 — Assemble the net.

\Delta \text{ATP}_{\text{net}} = -2\,(\text{investment}) + 2\times\big[(+1) + (+1)\big]\,(\text{payoff, per GAP}) = -2 + 4 = +2

\Delta \text{NADH}_{\text{net}} = 2\times(+1)\,(\text{GAPDH, per GAP}) = +2

Limiting-case check: if the cleavage step produced only one usable triose per glucose (as it would if DHAP were simply discarded rather than isomerized), the payoff phase would run only once, giving $\Delta\text{ATP}_{\text{net}} = -2 + 2 = 0$ and $\Delta\text{NADH}_{\text{net}} = +1$ — glycolysis would be energetically pointless. The existence and near-diffusion-limited efficiency of triose phosphate isomerase (a textbook "catalytically perfect" enzyme, $k_{cat}/K_M \approx 2\times10^8\ \text{M}^{-1}\text{s}^{-1}$ ) is precisely what rescues the second half of the sugar and makes the pathway profitable.

Go deeper · Derivation B · 2 minOverall free-energy accounting: why glycolysis is exergonic despite an endergonic step

Derivation BOverall free-energy accounting: why glycolysis is exergonic despite an endergonic step

Goal: show how the ten individual ΔG°′ values sum to the pathway total, and why physiological concentrations make the pathway far more favorable than standard-state numbers suggest.

Step 1 — List the standard free energies (kJ/mol, per glucose-based turn; steps 6–10 counted once here per triose, then doubled at the end).

Step	Reaction	ΔG°′ (kJ/mol)
1	Glucose → G6P (hexokinase)	−16.7
2	G6P → F6P (isomerase)	+1.7
3	F6P → F1,6BP (PFK-1)	−14.2
4	F1,6BP → DHAP + GAP (aldolase)	+23.9
5	DHAP → GAP (TPI)	+7.5
6	GAP → 1,3-BPG (GAPDH)	+6.3
7	1,3-BPG → 3PG (PGK)	−18.8
8	3PG → 2PG (mutase)	+4.6
9	2PG → PEP (enolase)	+1.8
10	PEP → Pyruvate (PK)	−31.4

Step 2 — Sum steps 1–5 once (they occur once per glucose) and steps 6–10 twice (they occur once per triose, two trioses per glucose).

\Delta G^{\circ\prime}_{1\text{–}5} = -16.7 + 1.7 - 14.2 + 23.9 + 7.5 = +2.2\ \text{kJ/mol}

\Delta G^{\circ\prime}_{6\text{–}10,\ \text{one triose}} = 6.3 - 18.8 + 4.6 + 1.8 - 31.4 = -37.5\ \text{kJ/mol}

\Delta G^{\circ\prime}_{\text{total}} = \Delta G^{\circ\prime}_{1\text{–}5} + 2\times\Delta G^{\circ\prime}_{6\text{–}10,\text{one triose}} = 2.2 + 2(-37.5) = 2.2 - 75.0 = -72.8\ \text{kJ/mol}

This differs from the commonly quoted −146 kJ/mol figure because that number already folds in the coupled ATP hydrolysis/synthesis free energies at cellular (not standard 1 M) concentrations for the phosphoryl-transfer steps; different textbooks partition the accounting differently (some report the "glucose-to-pyruvate" ΔG°′ using measured metabolite concentrations rather than pure standard-state values). The internally consistent standard-state sum shown here, using only the ten intrinsic reaction free energies, gives ≈ −73 kJ/mol; folding in the physiological [ATP]/[ADP][Pᵢ] ratio (which is far from 1, making ATP synthesis less favorable than standard state and ATP hydrolysis more favorable) pushes the realized cellular ΔG substantially more negative, consistent with the −70 to −100 kJ/mol range quoted for whole-pathway flux in vivo.

Step 3 — Explain the endergonic outlier. Step 4 (aldolase) is the most endergonic single step (+23.9 kJ/mol at standard state) because it breaks a C–C bond without forming a compensating strong bond — pure bond cleavage costs energy. It runs forward in the cell only because downstream consumption of GAP (via the highly exergonic GAPDH/PGK/PK sequence) keeps the effective mass-action ratio $Q < K_{eq}$ , making the local ΔG negative even though ΔG°′ is positive. This is the same "pull" logic used throughout metabolism: a thermodynamically uphill step is rendered kinetically forward-only by tight coupling to an downstream exergonic sink, a principle you will see again in the linkage between glycolysis and the electron-transport chain via NADH reoxidation.

Step 4 — Physiological correction.

\Delta G = \Delta G^{\circ\prime} + RT \ln\!\left(\frac{[\text{products}]}{[\text{reactants}]}\right)

For the aldolase step specifically, cellular [F1,6BP] is kept low and [DHAP]+[GAP] relatively higher by rapid downstream flux, so $Q \ll K_{eq}$ and $RT\ln Q$ is strongly negative, overcoming the positive ΔG°′. Using typical erythrocyte concentrations (F1,6BP ≈ 0.023 mM, DHAP ≈ 0.15 mM, GAP ≈ 0.007 mM, T = 310 K):

\Delta G = 23.9 + (8.314\times10^{-3})(310)\ln\!\left(\frac{(1.5\times10^{-4})(7\times10^{-6})}{2.3\times10^{-5}}\right)

\Delta G = 23.9 + 2.577\ln(4.57\times10^{-5}) = 23.9 + 2.577(-9.99) \approx 23.9 - 25.7 \approx -1.8\ \text{kJ/mol}

The step becomes slightly exergonic under real cellular conditions — a direct, numerically explicit illustration of why standard-state ΔG°′ can be the wrong sign for predicting physiological directionality.

Worked examples

Example 1 — Foundational: tracing one carbon atom through the pathway. Label glucose's carbons C1 through C6 (C1 = aldehyde carbon in the open form). After hexokinase and phosphoglucose isomerase, F6P retains the same backbone numbering (fructose numbering shifts the carbonyl to C2, but the physical carbon atoms map 1:1 onto glucose's numbering by convention in most texts, with glucose C1 becoming fructose C1). PFK-1 phosphorylates C1; aldolase then cleaves the C3–C4 bond:

\text{F1,6BP (C1–C6)} \rightarrow \underbrace{\text{DHAP (C1, C2, C3)}}_{\text{ketose, phosphate on C1}} + \underbrace{\text{GAP (C4, C5, C6)}}_{\text{aldose, phosphate on C6}}

Triose phosphate isomerase converts DHAP to GAP by moving the carbonyl from C2 to C1 (an isomerization through a cis-enediol intermediate), so the original glucose C1 becomes the aldehyde carbon of a second GAP molecule, chemically indistinguishable from the GAP derived directly from C4–C6. This means glucose's C3 and C4 (the bond that was cleaved) end up, after the full pathway, as the carboxylate carbons of the two pyruvate molecules — a fact exploited in classic isotope-tracing experiments (using ¹⁴C-labeled glucose at specific positions) that first confirmed the aldolase cleavage site and the isomerase step in the 1940s–50s.

Example 2 — Applied: ATP and NADH yield for 5 mmol of glucose consumed by exercising muscle in one minute, assuming glycolysis runs to pyruvate only (no further oxidation, e.g., during a brief anaerobic burst). Per the net stoichiometry:

\text{Glucose} \rightarrow 2\,\text{Pyruvate} + 2\,\text{ATP} + 2\,\text{NADH}

For 5 mmol glucose:

n_{\text{ATP}} = 5\ \text{mmol} \times 2 = 10\ \text{mmol ATP produced (substrate-level phosphorylation)}

n_{\text{NADH}} = 5\ \text{mmol} \times 2 = 10\ \text{mmol NADH produced}

Because this scenario is explicitly anaerobic (no downstream oxidation), the muscle cannot use the electron-transport chain to reoxidize NADH; instead lactate dehydrogenase regenerates NAD⁺ by reducing pyruvate to lactate (the fermentation branch elaborated in Fates of Pyruvate and Fermentation), consuming the 10 mmol NADH and yielding 10 mmol lactate, with no additional ATP from that step. Net over one minute: 10 mmol ATP, all from glycolysis itself — illustrating why fast-twitch muscle relies on glycolysis for rapid, oxygen-independent ATP even though the yield per glucose (2 ATP) is more than an order of magnitude smaller than complete aerobic oxidation (~30–32 ATP via the citric acid cycle and oxidative phosphorylation).

Example 3 — Exam/competition level: computing the actual (non-standard) ΔG for pyruvate kinase in a liver cell, and testing whether the step is truly irreversible in vivo. Given typical hepatocyte concentrations: [PEP] = 23 μM, [ADP] = 140 μM, [pyruvate] = 51 μM, [ATP] = 2.6 mM, T = 310 K, and ΔG°′(PK) = −31.4 kJ/mol for

\text{PEP} + \text{ADP} \rightarrow \text{Pyruvate} + \text{ATP}

Compute the reaction quotient:

Q = \frac{[\text{Pyruvate}][\text{ATP}]}{[\text{PEP}][\text{ADP}]} = \frac{(5.1\times10^{-5})(2.6\times10^{-3})}{(2.3\times10^{-5})(1.4\times10^{-4})}

Q = \frac{1.326\times10^{-7}}{3.22\times10^{-9}} \approx 41.2

Now apply the free-energy relation:

\Delta G = \Delta G^{\circ\prime} + RT\ln Q = -31.4 + (8.314\times10^{-3})(310)\ln(41.2)

\Delta G = -31.4 + (2.577)(3.72) = -31.4 + 9.59 \approx -21.8\ \text{kJ/mol}

Despite the reaction quotient being well above 1 (products favored 41-fold over the standard-state ratio), the actual ΔG remains strongly negative, confirming pyruvate kinase operates far from equilibrium in the forward direction under normal hepatic conditions — consistent with its classification as one of the three essentially irreversible, regulated steps of glycolysis. Limiting case: if [ATP] were instead held at a hypothetical 25 mM (a ~10-fold pathological elevation) with all else fixed, $Q$ would rise to ≈ 412, $RT\ln Q \approx 2.577 \times 6.02 \approx 15.5$ kJ/mol, giving $\Delta G \approx -15.9$ kJ/mol — still favorable, illustrating the large kinetic margin built into this step's standard free energy, which is why cells can tolerate substantial swings in adenine nucleotide ratios without reversing pyruvate kinase.

Limiting cases, scope & common traps

Scenario	What happens to the pathway	Why
No O₂ available	NADH cannot be reoxidized by the ETC; pyruvate is reduced to lactate (or ethanol + CO₂ in yeast) to regenerate NAD⁺	Glycolysis needs a continuous NAD⁺ supply at the GAPDH step; fermentation is purely an NAD⁺-regeneration device, not an extra energy source
Fructose entering via fructokinase (liver)	Bypasses hexokinase/PFK-1 regulation, enters as F1P then cleaved by aldolase B	Skips the pathway's main control points, part of why excess dietary fructose is metabolically "unregulated" compared to glucose
Red blood cells (no mitochondria)	Glycolysis (plus lactate fermentation) is the only ATP source	No citric acid cycle or oxidative phosphorylation possible without mitochondria
[F1,6BP] artificially high, [F6P] low ( $Q \gg 1$ locally)	Aldolase can transiently run in reverse in vitro	Demonstrates the step is near-equilibrium; only continuous downstream draw keeps it forward physiologically
Only one triose (DHAP) considered, TPI ignored	Net ATP mistakenly computed as 0 instead of +2	Common student error — forgetting that DHAP must isomerize to GAP before the payoff phase can process it
High cellular ATP/ADP ratio	PFK-1 allosterically inhibited (ATP is also a substrate but binds a separate inhibitory site)	Classic feedback control: abundant energy charge slows further glucose breakdown regardless of substrate availability

Common trapTwo common misconceptions

First, students often assume every step of glycolysis makes or spends ATP; in fact only four of the ten steps involve ATP at all (hexokinase and PFK-1 spend it; phosphoglycerate kinase and pyruvate kinase make it), and only one step (GAPDH) is a redox reaction. The other six are isomerizations, a dehydration, and the aldol cleavage/reformation — no phosphoryl transfer to or from adenine nucleotides occurs there. Second, the oft-quoted "2 ATP net, 2 NADH net" yield is sometimes mistakenly treated as the total energetic output of glucose metabolism. It is only the yield of glycolysis itself, stopping at pyruvate. The NADH generated must still be reoxidized (via the electron transport chain aerobically, worth roughly 2.5 ATP each after accounting for shuttle costs, or via fermentation anaerobically, worth zero additional ATP), and pyruvate itself carries the large majority of glucose's remaining chemical potential energy into the citric acid cycle.

The chemist behind it

Glycolysis was elucidated collectively over roughly four decades by a remarkable set of biochemists working across Germany, Britain, and the United States, but if one figure anchors the pathway's discovery it is Otto Fritz Meyerhof, who — building on Louis Pasteur's observation that fermentation could occur without oxygen and on Eduard Buchner's 1897 demonstration that cell-free yeast extracts could ferment sugar — established the quantitative relationship between glycogen breakdown, lactic acid production, and heat release in contracting muscle. Meyerhof's meticulous calorimetric measurements in the 1920s showed that the lactic acid produced during muscular contraction was resynthesized back to glycogen during recovery using oxidative energy, tying anaerobic and aerobic metabolism together for the first time in a quantitative energy-balance framework — work for which he shared the 1922 Nobel Prize in Physiology or Medicine with A.V. Hill. The specific enzymatic steps were filled in through the work of Gustav Embden (who proposed much of the phosphorylated intermediate sequence shortly before his death in 1933), Jacob Parnas, Carl and Gerty Cori (who characterized glycogen phosphorylase and the Cori cycle linking muscle lactate to hepatic gluconeogenesis, Nobel Prize 1947), and Otto Warburg (who purified several glycolytic enzymes and cofactors, including establishing the role of NAD⁺, and later described the aerobic glycolysis phenomenon in tumor cells that bears his name). The pathway is accordingly often called the Embden–Meyerhof–Parnas (EMP) pathway in recognition of this collaborative, multi-decade effort — a reminder that, unlike many named laws in physics, major metabolic pathways are rarely the achievement of one person working alone.

Origins · 1 minOtto Fritz Meyerhof and how this was discovered

Otto Fritz Meyerhof

1884–1951 · Biochemist, Kiel/Heidelberg/Philadelphia; established the energetic coupling between anaerobic glycolysis and muscle contraction, Nobel Prize in Physiology or Medicine 1922 (shared with A. V. Hill)

History

- 1897 — Eduard Buchner shows cell-free yeast extract ferments sugar, founding biochemical enzymology.

- 1905 — Arthur Harden and William Young discover the requirement for inorganic phosphate in fermentation and isolate fructose-1,6-bisphosphate ("Harden–Young ester").

- 1918–1930 — Otto Meyerhof quantifies the energy balance of lactic acid production and resynthesis in muscle.

- 1933 — Gustav Embden proposes the core sequence of phosphorylated intermediates shortly before his death.

- 1940 — The full ten-step Embden–Meyerhof–Parnas pathway, including aldolase cleavage and NAD⁺-linked oxidation, is essentially complete.

Why does glycolysis "waste" ATP at the start instead of immediately harvesting glucose's energy?

The two ATP-spending steps (hexokinase, PFK-1) aren't waste — they are activation energy in the chemical sense. Neutral glucose is kinetically stable and membrane-permeant; phosphorylating it traps it inside the cell (phosphorylated sugars cannot cross most membranes) and destabilizes the molecule enough that a subsequent retro-aldol cleavage becomes thermodynamically accessible. Without this "investment," fructose-1,6-bisphosphate's symmetric, doubly charged structure — the actual substrate for cleavage — would never form. The 2 ATP spent are repaid fourfold (4 ATP made in the payoff phase), for a net profit of 2 ATP, so the strategy is net favorable even though it looks like a loss at first glance.

Why is the net yield only 2 ATP when the citric acid cycle and oxidative phosphorylation yield roughly 30?

Glycolysis performs only a partial oxidation of glucose — it converts glucose (oxidation state of carbon roughly 0 on average) to pyruvate (a more oxidized three-carbon acid), extracting only a fraction of the total combustion energy (2870 kJ/mol) as 2 ATP plus 2 NADH. The remaining energy stays locked in pyruvate's carbon skeleton and is only released by fully oxidizing pyruvate to CO₂ via the citric acid cycle, with the resulting large pool of NADH and FADH₂ feeding the electron transport chain, where oxygen serves as the ultimate electron acceptor. Glycolysis is deliberately "shallow" so that it can run without oxygen at all — a tradeoff between yield and universality.

Does glycolysis require oxygen at any step?

No single glycolytic enzyme uses molecular oxygen as a substrate or cofactor. The pathway's only requirement is a continuous supply of oxidized NAD⁺ for the GAPDH step. Under aerobic conditions, NAD⁺ is regenerated by the electron transport chain (indirectly, since NADH itself cannot cross the mitochondrial inner membrane and must use shuttle systems). Under anaerobic conditions, NAD⁺ is regenerated instead by reducing pyruvate to lactate (animals) or acetaldehyde to ethanol (yeast), which is why glycolysis can proceed to completion with zero oxygen present, as it does in exercising muscle during oxygen debt or in obligate anaerobic microorganisms.

Why is fructose-1,6-bisphosphate cleaved specifically between C3 and C4, rather than at some other bond?

The cleavage site is dictated by the mechanism, not arbitrary convention. Aldolase's retro-aldol chemistry requires a carbonyl group (at C2 of fructose) positioned so that the C3–C4 bond is beta to that carbonyl; cleavage generates one fragment bearing the original carbonyl as an enolate/Schiff base (which becomes DHAP after protonation) and one fragment bearing a new aldehyde at what was C4 (which becomes GAP). Because F1,6BP is phosphorylated symmetrically at C1 and C6, the two three-carbon products each retain exactly one phosphate group, which is essential — both trioses must be phosphorylated to remain trapped inside the cell and to serve as substrates for the payoff-phase enzymes.

Why are hexokinase, PFK-1, and pyruvate kinase singled out as "control points" but not the other seven enzymes?

These three catalyze reactions with large negative ΔG°′ values (roughly −17, −14, and −31 kJ/mol respectively) that are essentially irreversible under cellular conditions — the reverse reaction never happens physiologically. Because flux through an irreversible step can be controlled without disturbing the near-equilibrium steps around it, evolution has concentrated allosteric regulation (by ATP, AMP, citrate, fructose-2,6-bisphosphate, and others) precisely at these three points. The other seven steps operate close to equilibrium in vivo, meaning their forward and reverse rates are nearly balanced and flux through them is dictated passively by substrate and product concentrations rather than by dedicated regulatory sites.

How does glycolysis connect to fat and protein metabolism?

Glycolytic intermediates are metabolic hubs, not just a linear conduit to pyruvate. Dihydroxyacetone phosphate can be reduced to glycerol-3-phosphate, the glycerol backbone for triglyceride and phospholipid synthesis. 3-phosphoglycerate can be diverted into serine biosynthesis. Pyruvate itself can be transaminated to alanine or carboxylated to oxaloacetate (anaplerosis feeding the citric acid cycle) instead of being decarboxylated to acetyl-CoA. This branching makes glycolysis not merely an energy pathway but a biosynthetic staging ground, which is part of why its regulation (particularly at PFK-1) integrates signals about the cell's broader biosynthetic and energetic state, not glucose availability alone.

What happens to the 2 ATP and 2 NADH numbers if a cell metabolizes fructose or galactose instead of glucose?

Fructose entering via fructokinase in the liver is phosphorylated to fructose-1-phosphate, cleaved by a distinct aldolase B isoform into DHAP and glyceraldehyde, and the glyceraldehyde is separately phosphorylated by triose kinase before merging with the main pathway at the triose phosphate stage — net ATP yield per fructose is essentially the same 2 ATP, but the sugar enters downstream of PFK-1, bypassing that major control point (part of why excessive dietary fructose can drive relatively unregulated glycolytic flux). Galactose, after conversion to glucose-1-phosphate via the Leloir pathway and isomerization to glucose-6-phosphate, enters glycolysis at exactly the point glucose does after step 1, yielding the identical 2 ATP and 2 NADH per molecule.